United States Biodegradable Stents Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

The Global Biodegradable Stents Market is expected to grow at a CAGR of 5% during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/biodegradable-stents-market?sb

Key Development:

United States: Recent Industry Developments

✅ In February 2026, researchers reported advances in controlled drug‐delivery systems using chitosan‐coated nanoporous nitinol alloys that improve localized drug release for cardiovascular stent applications, indicating next‐gen biodegradable stent technologies with enhanced therapeutic control.

✅ In December 2025, clinical implantation of a next‐generation gradient absorption biodegradable scaffold with zoned degradation profiles was reported, featuring inner zones resorbing within ~12 months and outer zones up to 24 months to optimize vessel healing in human subjects.

✅ In December 2025, industry reports noted over 50 ongoing clinical trials evaluating next‐gen biodegradable scaffolds featuring nanoporous coatings and drug‐eluting capabilities, reflecting intensifying R&D and pipeline activity in bioresorbable vascular devices.

✅ In December 2025, The continuous refinements of biodegradable polymer blends and microcatheter delivery designs to enhance safety, deliverability, and controlled absorption underlining recent innovation trends in U.S. biodegradable stent platforms.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biodegradable-stents-market

Japan: Recent Industry Developments

✅ In February 2026, industry analysis of the Japanese biodegradable drug coating coronary stent system market underscored expanding R&D efforts and strategic positioning by domestic and multinational firms to capture emerging opportunities in advanced bioresorbable stent technologies.

✅ In January 2026, clinical and industry forums in Japan highlighted collaborative research into novel bioresorbable stent materials and deployment techniques, aligning with global momentum toward next‐generation biodegradable cardiovascular devices.

✅ In December 2025, market outlook for biodegradable stents in Japan pointed to growing adoption of bioresorbable designs in cardiovascular treatments, driven by continual device innovation and evolving clinical preferences for minimally invasive solutions.

✅ In December 2025, reports noted enhancements in biodegradable stent materials and design trends gaining traction in Japan, including reductions in strut thickness and optimized degradation profiles to improve deliverability and vessel healing.

Key Players:

=> Boston Scientific Corporation, Arterius Limited, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd, Terumo Corporation, Abbott Laboratories Inc., Amaranth Medical, and Biotronik, Meril Life Sciences Pvt. Ltd and Reva Medical.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biodegradable-stents-market?sb

Key Segments:

By Product Type

Coronary Artery Stents dominate the market with an estimated 60% share, driven by high prevalence of coronary artery disease (CAD) and increasing adoption of minimally invasive procedures in hospitals and cardiac catheterization laboratories. Technological advancements, including drug-eluting stents, are further boosting demand.

Peripheral Artery Stents account for 40%, supported by rising incidence of peripheral artery disease (PAD), aging populations, and increased awareness for early diagnosis and intervention. Growth is particularly strong in emerging markets where PAD prevalence is on the rise.

By Material

Metallic Stents lead the market with 55% share, owing to their durability, proven clinical performance, and widespread adoption in both coronary and peripheral interventions.

Polymer-Based Stents capture 35%, driven by innovation in bioresorbable and drug-eluting stents that reduce long-term complications and enhance patient outcomes.

Other Materials contribute 10%, including hybrid or coated stents, representing niche adoption in specialized procedures.

By End-Users

Hospitals account for 50% share, as most stenting procedures are performed in fully equipped hospitals with catheterization labs and cardiac care units.

Cardiac Catheterization Laboratories hold 30%, reflecting their increasing role in minimally invasive cardiovascular interventions and outpatient stenting procedures.

Ambulatory Surgery Centers (ASCs) contribute 20%, growing due to shorter recovery times and the trend toward same-day procedures in certain regions.

By Region

North America dominates with around 38% share, driven by high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong adoption of next-generation stents.

Europe follows with 27%, supported by established healthcare systems, reimbursement support, and growing awareness for early intervention.

Asia Pacific captures 25%, fueled by increasing cardiovascular disease burden, rising healthcare access, and growing investments in interventional cardiology facilities.

Latin America and Middle East & Africa collectively hold 10%, reflecting emerging healthcare infrastructure and increasing procedural volumes.

Outlook & Opportunity Analysis (2024-2031)

The global stent market is projected to grow steadily, driven by rising incidence of coronary and peripheral artery diseases, advancements in drug-eluting and bioresorbable stents, and expansion of minimally invasive cardiovascular procedures. Opportunities exist in emerging markets, bioabsorbable stents, and next-generation polymer-based materials, which are expected to reshape the treatment landscape over the forecast period.

FAQ

Q: What is the growth rate of the Biodegradable Stents Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.